Influenza and pneumococcal vaccination rates in patients with inflammatory bowel disease

Gastroenterology and Hepatology

Volumn 11, Issue 6, 2015, Pages 396-401

  Reich, Jason S ^a   Miller, Hannah L ^a   Wasan, Sharmeel K ^a   Noronha, Ansu ^a   Ardagna, Eileen ^a   Sullivan, Kathleen ^a   Jacobson, Brian ^a   Farraye, Francis A ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

Inflammatory bowel disease; Influenza; Pneumococcal; Pneumonia; Vaccination

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ARTICLE; HEALTH EDUCATION; HIGH RISK POPULATION; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLUENZA; INFLUENZA VACCINATION; MEDICAL INFORMATION; OUTCOME ASSESSMENT; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL VACCINATION; RISK ASSESSMENT; VACCINATION;

EID: 84937040700     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010;105(6):1231-1238.
2. PCV13 (pneumococcal conjugate) vaccine. Centers for Disease Control and Prevention. Accessed December 7, 2014. http://www.cdc.gov/vaccines/vpd-vac/pneumo/vac-PCV13-adults.htm.
3. Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2004;53(RR-6):1-40.
4. Melmed GY, Ippoliti AF, Papadakis KA, et al. Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006;101(8):1834-1840.
5. Centers for Disease Control and Prevention (CDC). Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations - United States 1996. MMWR Morb Mortal Wkly Rep. 1999;48(39):886-890.
6. Lashuay N, Tjoa T, Zuniga de Nuncio ML, Franklin M, Elder J, Jones M. Exposure to immunization media messages among African American parents. Prev Med. 2000;31(5):522-528.
7. Nichol KL. Long-term success with the national health objective for influenza vaccination: an institution-wide model. J Gen Intern Med. 1992;7(6):595-600.
8. Population and patient profile tables, charts and statistics: calendar year 2011. Boston University Medical Campus Clinical Research Resources Office. http://www.bumc.bu.edu/crro/files/2012/06/BMC-stats-2011.pdf. Accessed May 12, 2015.
9. Melmed GY. Vaccinations and the utilization of immunosuppressive IBD therapy. Gastroenterol Hepatol (N Y). 2008;4(12):859-861.
10. Parker S, Chambers White L, Spangler C, et al. A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD. Inflamm Bowel Dis. 2013;19(9):1809-1814.
11. Task Force on Community Preventive Services. Recommendations regarding interventions to improve vaccination coverage in children, adolescents, and adults. Am J Prev Med. 2000;18(1 suppl):92-96.
12. Klein RS, Adachi N. An effective hospital-based pneumococcal immunization program. Arch Intern Med. 1986;146(2):327-329.
13. Rhew DC, Glassman PA, Goetz MB. Improving pneumococcal vaccine rates. Nurse protocols versus clinical reminders. J Gen Intern Med. 1999;14(6):351-356.
14. Postema AS, Breiman RF; National Vaccine Advisory Committee. Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation. MMWR Recomm Rep. 2000;49(RR-1):1-13.
15. Nowalk MP, Zimmerman RK, Tabbarah M, Raymund M, Jewell IK. Determinants of adult vaccination at inner-city health centers: a descriptive study. BMC Fam Pract. 2006;7:2.
16. Panés J, O'Connor M, Peyrin-Biroulet L, Irving P, Petersson J, Colombel JF. Improving quality of care in inflammatory bowel disease: what changes can be made today? J Crohns Colitis. 2014;8(9):919-926.
17. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1997;46(RR-8):1-24.